Read more
5:59 PM · 11 November 2025

US100 loses 0.5%🚩

Futures on the Nasdaq 100 index (US100) are down about 0.5%, roughly 30 minutes before the start of the U.S. trading session. Investor sentiment has slightly weakened, despite progress on reopening the U.S. government. The main factor behind the decline appears to be a negative market reaction to CoreWeave’s (CRWV.US) earnings report — the company is one of the key suppliers of GPU infrastructure for data centers used by major tech giants, including Nvidia.

  • CoreWeave, once a significant Ethereum miner, has completely transformed its business model to capitalize on the artificial intelligence boom. The company now leases graphics processors and cooperates with major players such as Meta Platforms and OpenAI.
  • The latest NFIB index publication from the U.S. came in slightly below expectations. Sentiment among small American businesses — which account for nearly half of the U.S. workforce — weakened in October. The US NFIB Business Optimism Index stood at 98.20 points, compared with the forecast of 98.3 and the previous reading of 98.80. However, the scale of the negative surprise remains relatively minor.

In the coming weeks, delayed U.S. macroeconomic data will be closely watched. If the releases turn out to be particularly weak, investors could overreact to recession fears. On the other hand, the overall picture of the U.S. earnings season remains solid, and the Federal Reserve could still opt for an interest rate cut in December. If the U.S. government reopening process is finalized in the coming days, a renewed rally on Wall Street remains possible.

CoreWeave under pressure – stock down 8%

CoreWeave shares are dropping in premarket trading after the company cut its annual revenue forecast due to delays in launching a key data center, despite strong demand for its AI services.

  • The firm is struggling with rising infrastructure costs, higher GPU prices, and increasing competition for computing power, all of which are weighing on profitability. According to the company, the issues stemmed from cooperation with one of its major data center partners; however, the client agreed to extend the contract, keeping its total value unchanged.
  • Barclays analysts noted that the results revealed operational risks in the AI infrastructure sector, reminding investors that building large-scale data centers is a highly complex engineering challenge.
  • Since its IPO in March 2025, CoreWeave’s stock has surged more than 150%, but in the third quarter, its operating margin fell from 21% to 16%. Revenue reached $1.36 billion, above analysts’ expectations of $1.29 billion, though weaker profitability may become an issue once AI demand begins to cool.

Additional risk factors include the short lifecycle of GPU chips, the cyclicality of the industry, and the potential for write-downs on GPU assets. Despite the stock trading about 30% below its highs, CoreWeave’s market capitalization still stands at around $52 billion. The disappointing report has dampened sentiment across the broader AI infrastructure sector, with investors showing less conviction in the sustainability of its rapid growth.

Source: xStation5

US100 Technical Analysis 

H1 timeframe: The index pulled back after reaching the 25,700-point area. The contract is now hovering around the EMA50, which serves as a key intraday support level. The 25,700-point zone remains a strong resistance level from a price action perspective.

D1 timeframe: The index has defended short-term support near 25,200 points (EMA50, orange line). The RSI indicator remains neutral, around 53 points.

Source: xStation5

13 May 2026, 9:46 PM

Daily Summary: Hot inflation and awaiting for news from Beijing

13 May 2026, 8:30 PM

Trump–Xi: Who represents business and how are markets reacting?

13 May 2026, 6:56 PM

US OPEN: Higher inflation to cap gains?

13 May 2026, 6:05 PM

Birkenstock shares hit lowest level since IPO following earnings report 💥

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.